Healthcare Services

Global Microarray Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Microarray Market Across 2026–2030?

The microarray market size has demonstrated robust growth in recent years. This market is projected to expand from $5.62 billion in 2025 to $6.17 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. The growth observed in the preceding period can be linked to the increasing adoption of gene expression profiling, advancements in dna sequencing technologies, a rise in the utilization of microarrays in cancer research, the broadening of drug discovery programs, and the increasing prevalence of genetic disorders.

The microarray market is projected to experience substantial expansion in the coming years. Its size is forecast to reach $9.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.2%. This anticipated growth during the projection period stems from several factors, including the escalating demand for personalized medicine, progress in bioinformatics processing tools, the increasing adoption of automation within microarray workflows, broader applications in toxicological testing, and the heightened necessity for high-throughput genomic analysis. Key developments expected in the forecast period encompass genomics-driven microarray optimization, the utilization of cloud-based data processing for microarray analysis, AI-powered gene expression interpretation, automated microarray manufacturing systems, and IoT-enabled sample tracking and monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10742&type=smp

What Drivers Are Shaping The Future Growth Of The Microarray Market?

The increasing incidence of cancer cases is anticipated to drive the future growth of the microarray market. Cancer is defined as a condition where some of the body’s cells proliferate uncontrollably and spread to other areas. This rise in cancer cases primarily stems from a higher occurrence of established cancer risk factors, exposure to specific chemicals, an aging demographic, and common cancers such as breast cancer, lung cancer, and bronchial cancer, for which microarray technology enables researchers to detect changes in gene expression that may be linked to cancer. For instance, in January 2023, the American Cancer Society, a US-based voluntary health organization, reported that roughly 9,910 children in the US under the age of 15 were diagnosed with cancer, and about 1,040 children under the age of 15 died from cancer in 2023. Thus, the escalating incidence of cancer cases is propelling the growth of the microarray market.

What Segmentation Levels Are Considered In The Microarray Market?

The microarray market covered in this report is segmented –

1) By Type: DNA Microarray, Protein Microarray, Other Types

2) By Application: Disease Diagnosis, Cancer Genomic Analysis, Drug Discovery, Genomic Sequencing, Expression Analysis, Toxicological Research, Other Applications

3) By End-User: Pharmaceutical Industry, Biotechnology Industry, Academic and Research Laboratories, Other End-Users

Subsegments:

1) By DNA Microarray: CDNA Microarray, Oligonucleotide Microarray, SNP Microarray, Comparative Genomic Hybridization (CGH) Microarray

2) By Protein Microarray: Antibody Microarray, Antigen Microarray, Receptor Microarray, Enzyme Microarray

3) By Other Types: Cell Microarray, Tissue Microarray, RNA Microarray

How Are Trends Transforming The Microarray Market Landscape?

Leading companies within the microarray market are focusing their efforts on creating chromosomal microarrays to enhance their standing. Chromosomal Microarray Analysis (CMA) serves as a cutting-edge, transformative technology in genomic medicine, significantly advancing diagnostic potential. For instance, in August 2023, Thermo Fisher Scientific, Inc., a US-based provider of analytical instruments, life sciences solutions, specialty diagnostics, and laboratory, pharmaceutical, and biotechnology services, launched the Applied Biosystems CytoScan HD Accel array. This novel chromosomal microarray was designed to boost productivity, efficiency, and profitability in cytogenetic research laboratories. This innovative array features an industry-leading two-day turnaround time, marking a substantial improvement in the field. The Applied Biosystems CytoScan HD Accel array performs a comprehensive analysis of the entire human genome. With enhanced coverage extending across more than 5,000 critical genomic regions, it offers valuable insights into chromosomal variants. This sophisticated technology proves advantageous for a diverse array of applications, including prenatal and postnatal research, in addition to cancer-related studies.

Which Leading Firms Are Contributing To The Growth Of The Microarray Market?

Major companies operating in the microarray market are Agilent Technologies Inc., Arrayit Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare Inc., Illumina Inc., Merck KGaA, Microarray Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, RayBiotech Life Inc., Schott Minifab AG, Full Moon Biosystems Inc., CapitalBio Technology Co. Ltd., Roche Diagnostics Ltd., Affymetrix Inc., SCIENION AG, NextGen Sciences Inc., PathogenDx Inc., BioGenomics Limited, BioMicro Systems Inc., Biostatus Limited, Biotechrabbit GmbH, INanoBio Inc.

Read the full microarray market report here:

https://www.thebusinessresearchcompany.com/report/microarray-global-market-report

Which Geographic Regions Are Influencing Demand In The Microarray Market?

North America was the largest region in the microarray market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global microarray market report during the forecast period. The regions covered in the microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Microarray Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10742&type=smp

Browse Through More Reports Similar to the Global Microarray Market 2026, By The Business Research Company

Cone Beam Computed Tomography Global Market Report

https://www.thebusinessresearchcompany.com/report/cone-beam-computed-tomography-global-market-report

Medical Imaging Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report

Computed Tomography Ct Scanner Global Market Report

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanner-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795